We have 54 University of Bristol, Bristol Medical School PhD Projects, Programmes & Scholarships
University of Bristol, Bristol Medical School PhD Projects, Programmes & Scholarships
We have 54 University of Bristol, Bristol Medical School PhD Projects, Programmes & Scholarships
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Using Lessons Learnt from Alzheimer’s Disease to Untangle the Role of Tau and scope for new treatments in Sex Hormone Responsive Cancers
Tubulin associated unit, or as it is also called, Microtubiln Associated Tau Protein (MAPT) has been extensively studied in neurodegenerative diseases including Alzheimer’s disease (AD), whereby its hyperphosphorylation and accumulation contributes to disease pathogenesis in most cases. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - User-centred development of a digital intervention to support strength training in people with rheumatoid arthritis
Rheumatoid arthritis (RA) is the most common inflammatory arthritis in the UK affecting around 1% of the population(1). RA is a chronic autoimmune condition where the body’s immune system attacks cells in the body causing pain, inflammation, and joint swelling. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Understanding the role of adiponectin in kidney disease development at a population level
Reduced circulating adiponectin levels are associated with poor outcome in patients with diabetic kidney disease (DKD). Adiponectin has been shown to be protective against the development of DKD in Type 2 diabetic models. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Quantifying prognosis in the current era of antiretroviral therapy among persons with HIV in Europe and North America across different HIV acquisition route groups
In Europe and North America, prognosis for persons with HIV (PHIV) has improved since the introduction of combined antiretroviral therapy (ART) in 1996[1]. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Mental health during the menopausal transition
Despite the increasing media coverage concerning the impacts of the menopause on women’s wellbeing, this remains an under-researched area. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage – Medicines and early pregnancy loss: the role of population-wide, linked electronic health record resources
Most women take a prescription drug at some point during their pregnancy, especially in the first trimester when many do not know that they are pregnant. … Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Measurement of mental health in ethnically and geographically diverse populations
A range of tools are available to support the diagnosis of mental health conditions, assess response to treatment, and conduct mental health research. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Intersectional inequalities and mental health of young people with a disability or chronic illness
The proportion of 11-16-year-olds with a probable mental disorder rose from 13% in 2017 to 23% in 2023 (NHS Digital 2023). Mental health is shaped by social descriptors (e.g., gender, ethnicity, sexual orientation, disability, socioeconomic position) (10) and social, economic, and physical environments (11). Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - From birth to delivery: lifelong preconception health
There is an accumulating body of evidence suggesting that pregnancy is a whole-body stress test, identifying women who have an existing increased propensity for cardiovascular disease, common mental health conditions, and autoimmune disease. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Developing the tools to detect, protect and monitor blood vessels ‘non-stick’ lining to limit cardiovascular disease
The innermost, ‘non-stick’ layer of blood vessels is a complex interwoven mixture of sugars and proteins (endothelial glycocalyx (eGlx)).1 This layer is vital to blood vessel function.1,2. Read more
Funded PhD open to UK-domiciled, home fee applicants of Black African, Black Caribbean or other Black or mixed Black heritage - Developing ex vivo assays for drug development in kidney disease
Kidney disease is a UK health emergency with more than 10% of the population having chronic kidney disease (CKD). The annual cost of managing kidney disease in the UK is £7billion, equating to 3.2% of NHS budgets. Read more
Why are women underrepresented in cardiac surgery randomised controlled trials and what can be done to address this?
There are around 32,000 cardiac surgeries carried out annually in the UK, and about a quarter are female patients (1). Read more
Using multivariable Mendelian Randomization to identify and estimate the effects of drug targets on disease progression in cardiometabolic health
Cardiometabolic diseases are a leading cause of ill health throughout the world and so understanding the causal effect of potential drug targets on progression of these diseases among individuals who already have the disease is vital to improving health outcomes and reducing the burden of disease in society. Read more
The management of young people's mental health in primary care
Before the COVID-19 pandemic, new prescriptions for medication used to treat anxiety and depression were increasing in young people [1, 2]. Read more
Quantifying prognosis in the current era of antiretroviral therapy among persons with HIV in Europe and North America across different HIV acquisition route groups
In Europe and North America, prognosis for persons with HIV (PWHIV) has improved since the introduction of combined antiretroviral in 1996[1]. Read more